近2年来,我协作组采用甘利欣注射液治疗慢性乙型肝炎(活动型)507例,经临床验证,取得明显疗效,现将结果报告如下。 1 资料和方法 1.1 病例选择:按1990年全国第6次病毒性肝炎学术讨论会修订的诊断标准。临床诊断为慢性乙型肝炎(活动型)507例为治疗组(A),采用甘利欣治疗,以相同诊断的300例为对照组(B),采用强力宁治疗。两组病例在年龄、性别、病情、病程方面无统计学差异 In the past 2 years, our collaborative group used Ganlixin injection in the treatment of 507 chronic hepatitis B patients (active type), and the clinical trial proved that the curative effect has been achieved. The results are reported as follows. 1 Materials and Methods 1.1 Case Selection: According to the 1990 National 6th Symposium on viral hepatitis revised diagnostic criteria. Clinical diagnosis of chronic hepatitis B (active type) 507 cases for the treatment group (A), the use of Glycyrrhizin treatment, 300 cases of the same diagnosis as the control group (B), the use of powerful Ning treatment. There was no significant difference between the two groups in terms of age, sex, illness and course of disease